Neurocrine Biosciences, Inc. (NBIX) Social Stream



Neurocrine Biosciences, Inc. (NBIX): $145.69

1.55 (+1.08%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add NBIX to Watchlist
Sign Up

NEUROCRINE BIOSCIENCES INC (NBIX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NBIX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 20 $150 $100 $123.5 $130.58 -5.42%
2021-11-17 20 $150 $100 $123.222 $130.58 -5.63%
2021-11-19 20 $150 $76 $120.736 $130.58 -7.54%
2021-12-07 21 $150 $76 $120.736 $130.58 -7.54%
2022-01-07 22 $154 $76 $122 $130.58 -6.57%
2022-01-10 22 $154 $76 $121.789 $130.58 -6.73%
2022-01-18 22 $154 $76 $120.263 $130.58 -7.9%
2022-01-26 22 $154 $76 $119.052 $130.58 -8.83%
2022-01-30 22 $154 $76 $117.157 $130.58 -10.28%
2022-01-31 21 $154 $76 $116.842 $130.58 -10.52%
2022-02-14 21 $154 $76 $116.473 $130.58 -10.8%
2022-02-16 21 $150 $76 $115.684 $130.58 -11.41%
2022-02-25 21 $150 $76 $115.65 $130.58 -11.43%
2022-03-03 21 $150 $76 $114.6 $130.58 -12.24%
2022-04-12 20 $150 $76 $114.65 $130.58 -12.2%
2022-04-21 19 $150 $76 $114.55 $130.58 -12.28%
2022-05-04 20 $150 $76 $114.8 $130.58 -12.08%
2022-05-05 20 $150 $76 $114.6 $130.58 -12.24%
2022-05-06 19 $150 $76 $114.4 $130.58 -12.39%
2022-05-10 19 $150 $76 $114.368 $130.58 -12.42%
2022-06-02 19 $150 $76 $114.315 $130.58 -12.46%
2022-06-06 19 $150 $76 $113.578 $130.58 -13.02%
2022-08-01 19 $150 $76 $113.736 $130.58 -12.9%
2022-08-05 20 $150 $76 $114.052 $130.58 -12.66%
2022-08-13 20 $150 $76 $114.5 $130.58 -12.31%
2022-08-18 20 $150 $76 $114.9 $130.58 -12.01%
2022-09-21 20 $150 $76 $115.55 $130.58 -11.51%
2022-09-26 20 $150 $76 $115.285 $130.58 -11.71%
2022-10-11 21 $150 $76 $116.227 $130.58 -10.99%
2022-10-13 21 $150 $76 $116.818 $130.58 -10.54%
2022-10-20 22 $150 $76 $116.304 $130.58 -10.93%
2022-10-21 22 $150 $76 $116.347 $130.58 -10.9%
2022-10-24 21 $150 $76 $116.608 $130.58 -10.7%
2022-11-02 21 $150 $91 $121.478 $130.58 -6.97%
2022-11-03 21 $150 $101 $125.391 $130.58 -3.97%
2022-11-14 22 $150 $101 $126.043 $130.58 -3.47%
2023-01-17 21 $150 $101 $126.043 $130.58 -3.47%
2023-01-26 21 $150 $101 $126.13 $130.58 -3.41%
2023-01-30 21 $150 $101 $126 $130.58 -3.51%
2023-02-07 21 $150 $101 $126.739 $130.58 -2.94%
2023-02-08 21 $150 $95 $126.043 $130.58 -3.47%
2023-02-13 21 $150 $95 $126.956 $130.58 -2.78%
2023-02-23 21 $150 $95 $126.217 $130.58 -3.34%
2023-04-05 21 $150 $95 $126.217 $130.58 -3.34%
2023-04-12 21 $150 $95 $125.739 $130.58 -3.71%
2023-04-17 21 $150 $95 $125.608 $130.58 -3.81%
2023-04-20 21 $150 $95 $125.434 $130.58 -3.94%
2023-05-01 21 $150 $95 $125.391 $130.58 -3.97%
2023-05-05 23 $150 $95 $124.208 $130.58 -4.88%
2023-06-01 23 $150 $95 $124.166 $130.58 -4.91%
2023-06-06 23 $150 $95 $123.333 $130.58 -5.55%
2023-07-06 24 $150 $95 $123.208 $130.58 -5.65%
2023-07-14 24 $150 $95 $122.916 $130.58 -5.87%
2023-07-27 24 $150 $95 $122.916 $130.58 -5.87%
2023-08-02 24 $150 $95 $123 $130.58 -5.8%
2023-08-03 25 $150 $95 $123.833 $130.58 -5.17%
2023-08-22 24 $154 $95 $124.913 $130.58 -4.34%
2023-09-07 24 $154 $95 $125.26 $130.58 -4.07%
2023-09-13 25 $160 $95 $127.416 $130.58 -2.42%
2023-09-26 25 $160 $95 $127.791 $130.58 -2.14%
2023-10-05 25 $160 $95 $128.333 $130.58 -1.72%
2023-10-08 24 $165 $95 $130.545 $130.58 -0.03%
2023-10-25 24 $165 $95 $131 $130.58 0.32%
2023-10-31 24 $165 $95 $131.181 $130.58 0.46%
2023-11-01 24 $165 $95 $131.863 $130.58 0.98%
2023-11-02 24 $170 $100 $133.136 $130.58 1.96%
2023-11-03 24 $170 $100 $133.272 $130.58 2.06%
2023-11-10 24 $170 $100 $131.59 $130.58 0.77%
2023-11-13 24 $170 $100 $131.772 $130.58 0.91%
2023-11-21 24 $170 $100 $132 $130.58 1.09%
2023-12-06 24 $170 $100 $131.909 $130.58 1.02%
2023-12-07 24 $170 $100 $132.666 $130.58 1.6%
2023-12-13 24 $170 $100 $132.818 $130.58 1.71%
2023-12-15 24 $170 $100 $133.59 $130.58 2.31%
2023-12-20 24 $170 $100 $133.727 $130.58 2.41%
2023-12-29 24 $170 $100 $135.5 $130.58 3.77%

The Trend in the Analyst Price Target


Over the past 43 months, NBIX's average price target has gone up $11.11.

Over the past 50 weeks, NBIX's average upside potential has been 18.39%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-03 21 150 95 126.217 101.18 24.75%
2023-06-06 23 150 95 123.333 95.41 29.27%
2023-10-08 25 165 95 129.375 113.93 13.56%
2023-11-21 24 170 100 132.000 109.61 20.43%
2023-12-27 24 170 100 135.500 132.76 2.06%

NBIX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.46 18 1 5 0 0 24

The Trend in the Broker Recommendations


NBIX's average broker recommendation rating improved by 0.06 over the prior 47 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, NEUROCRINE BIOSCIENCES INC's number of analysts covering the stock is higher than 8853.69% of them.
  • In terms of how NEUROCRINE BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1086.48% of that group.
  • NEUROCRINE BIOSCIENCES INC's average analyst price target is greater than 8276.91% of Pharmaceutical Products stocks.
  • In the context of stocks in the large market cap category, NEUROCRINE BIOSCIENCES INC's variance in analysts' estimates is lower than -5897.24% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NEUROCRINE BIOSCIENCES INC are GILD, BIIB, and TECH.

What is the outlook for NBIX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!